Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa (MENA) region. Its GM, Zeina Sfeir Lahoud, discusses the company’s presence in over 17 countries, their 25 years of experience in Saudi Arabia, and the dynamics shaping the largest market in the region, including the fast regulatory approval process in place. With value-based healthcare an increasingly hot topic, she explains how Biologix has moved to sign the first risk-sharing agreement with Saudi Arabia for a spinal muscular atrophy product; the first in the MENA region.
STAY UP TO DATE NEWS & EVENTS
Related EVENTS & NEWS
Biologix at the 7th Omani Society of Hematology & 16th Arab Transfusion Medicine Forum
Biologix's Sponsorship and Participation at ACPN2023 in Dubai
Biologix has participated in the 15th Asian Congress of Pediatric Nephrology (ACPN2023) as a Diamond partner, taking place at the Marriott Hotel in Dubai, UAE, from November 23rd to 25th.
Rare Disease Day 2023
Our regional Rare Disease team came together to celebrate Rare Disease Day & show support to patients ...Read More
